
Keywords: Antimalarial; Poor-quality; Field survey; Review; Characterisation; Countermeasure; PQM; Poor-quality medicine; IntPro; Intellectual properties; GMP; Good manufacturing practices; NMRA; National medicine regulatory authority; API; Active pharmaceutical in